Abstract: The present invention relates to controlled/ extended release for human oral pharmaceutical compositions containing Terbinafine and or its salts that release the active ingredient over an extended period of time and this pharmaceutical composition can be a sustained release oral dosage form that release the drug in the pH environment of 1 to 3.5 continuously over a period of time using rate controlling polymers of hydrophilic and hydrophobic nature in homogenous admixture in presence of soluble and insoluble pharmaceutical components and process for preparation thereof.
| # | Name | Date |
|---|---|---|
| 1 | 1051-MUM-2005_EXAMREPORT.pdf | 2018-08-09 |
| 2 | 1051-MUM-2005-SPECIFICATION(AMENDED)-(3-4-2009).pdf | 2018-08-09 |
| 3 | 1051-MUM-2005-REPLY TO HEARING(8-5-2012).pdf | 2018-08-09 |
| 4 | 1051-MUM-2005-OTHER DOCUMENT(7-10-2009).pdf | 2018-08-09 |
| 5 | 1051-MUM-2005-FORM 5(3-4-2009).pdf | 2018-08-09 |
| 6 | 1051-MUM-2005-FORM 3(3-4-2009).pdf | 2018-08-09 |
| 7 | 1051-MUM-2005-FORM 26(3-4-2009).pdf | 2018-08-09 |
| 8 | 1051-MUM-2005-FORM 2(TITLE PAGE)-(3-4-2009).pdf | 2018-08-09 |
| 9 | 1051-MUM-2005-FORM 2(TITLE PAGE)-(22-8-2006).pdf | 2018-08-09 |
| 10 | 1051-MUM-2005-FORM 2(TITLE PAGE)-(21-5-2009).pdf | 2018-08-09 |
| 11 | 1051-mum-2005-form 2(3-4-2009).pdf | 2018-08-09 |
| 12 | 1051-mum-2005-form 2(22-8-2006).pdf | 2018-08-09 |
| 13 | 1051-mum-2005-form 2(21-5-2009).pdf | 2018-08-09 |
| 14 | 1051-MUM-2005-FORM 13(30-8-2006).pdf | 2018-08-09 |
| 15 | 1051-mum-2005-form 13(21-5-2009).pdf | 2018-08-09 |
| 16 | 1051-MUM-2005-FORM 1(31-8-2005).pdf | 2018-08-09 |
| 17 | 1051-MUM-2005-DESCRIPTION(COMPLETE)-(3-4-2009).pdf | 2018-08-09 |
| 18 | 1051-MUM-2005-DESCRIPTION(COMPLETE)-(22-8-2006).pdf | 2018-08-09 |
| 19 | 1051-MUM-2005-DESCRIPTION(COMPLETE)-(21-5-2009).pdf | 2018-08-09 |
| 20 | 1051-MUM-2005-CORRESPONDENCE(IPO)-(5-10-2012).pdf | 2018-08-09 |
| 21 | 1051-MUM-2005-CORRESPONDENCE(IPO)-(22-5-2008).pdf | 2018-08-09 |
| 22 | 1051-MUM-2005-CORRESPONDENCE(IPO)-(21-5-2009).pdf | 2018-08-09 |
| 23 | 1051-MUM-2005-CORRESPONDENCE(7-10-2009).pdf | 2018-08-09 |
| 24 | 1051-MUM-2005-CORRESPONDENCE(3-4-2009).pdf | 2018-08-09 |
| 25 | 1051-MUM-2005-CORRESPONDENCE(21-5-2009).pdf | 2018-08-09 |
| 27 | 1051-MUM-2005-CLAIMS(MARKED COPY)-(8-5-2012).pdf | 2018-08-09 |
| 28 | 1051-MUM-2005-CLAIMS(MARKED COPY)-(21-5-2009).pdf | 2018-08-09 |
| 29 | 1051-MUM-2005-CLAIMS(AMENEDED)-(21-5-2009).pdf | 2018-08-09 |
| 30 | 1051-MUM-2005-CLAIMS(AMENDED)-(8-5-2012).pdf | 2018-08-09 |
| 31 | 1051-MUM-2005-CLAIMS(AMENDED)-(3-4-2009).pdf | 2018-08-09 |
| 32 | 1051-MUM-2005-CLAIMS(3-4-2009).pdf | 2018-08-09 |
| 33 | 1051-MUM-2005-CLAIMS(22-8-2006).pdf | 2018-08-09 |
| 34 | 1051-MUM-2005-ABSTRACT(3-4-2009).pdf | 2018-08-09 |
| 35 | 1051-MUM-2005-ABSTRACT(22-8-2006).pdf | 2018-08-09 |